The Food and Drug Administration (FDA) is monitoring reports of severe dehydration in patients taking the type 2 diabetes drug Farxiga and has updated the “Warnings and Precautions” section on the safety label about the risk of acute kidney injury (AKI), according to the FDA’s April 1, 2016 to June 30, 2016, review of postmarket drug safety evaluations. The agency’s website provides summary information about ongoing and completed postmarket safety evaluations of adverse experience reports made to the FDA to determine if there are any new serious adverse events not previously identified during product development, known side effects reported in ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.